Steven Cohen Argenx Se Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $10.1 Million - $12.9 Million	-28,472 Reduced 45.05%	34,728 $14.9 Million
Q1 2024 May 15, 2024	SELL	$356.95 - $413.29 $19.6 Million - $22.7 Million	-54,900 Reduced 46.49%	63,200 $24.9 Million
Q4 2023 Feb 14, 2024	SELL	$338.91 - $506.01 $44.9 Million - $67 Million	-132,423 Reduced 52.86%	118,100 $44.9 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $92.5 Million - $137 Million	250,523 New	250,523 $123 Million
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $4.18 Million - $5.05 Million	12,500 New	12,500 $4.66 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $107 Million - $123 Million	-311,667 Reduced 54.21%	263,300 $93 Million
Q2 2022 Aug 15, 2022	SELL	$269.58 - $378.88 $58.4 Million - $82 Million	-216,457 Reduced 27.35%	574,967 $218 Million
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $98.7 Million - $136 Million	387,774 Added 96.07%	791,424 $250 Million
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $31.7 Million - $41.2 Million	116,603 Added 40.62%	403,650 $141 Million
Q3 2021 Nov 15, 2021	BUY	$295.0 - $350.58 $37.9 Million - $45 Million	128,347 Added 80.87%	287,047 $86.7 Million
Q2 2021 Aug 16, 2021	BUY	$257.11 - $319.92 $28.1 Million - $34.9 Million	109,200 Added 220.61%	158,700 $47.8 Million
Q1 2021 May 17, 2021	BUY	$268.3 - $380.31 $13.3 Million - $18.8 Million	49,500 New	49,500 $13.6 Million
Q3 2020 Nov 16, 2020	SELL	$215.51 - $272.51 $9.18 Million - $11.6 Million	-42,574 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $5.43 Million - $9.91 Million	42,574 New	42,574 $9.59 Million
Q4 2019 Feb 14, 2020	SELL	$106.59 - $164.21 $11.1 Million - $17.1 Million	-104,020 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$113.31 - $150.51 $1.52 Million - $2.02 Million	13,420 Added 14.81%	104,020 $11.9 Million
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $4.67 Million - $5.75 Million	40,600 Added 81.2%	90,600 $12.8 Million
Q1 2019 May 15, 2019	SELL	$98.85 - $134.59 $780,915 - $1.06 Million	-7,900 Reduced 13.64%	50,000 $6.24 Million
Q4 2018 Feb 14, 2019	BUY	$63.81 - $109.82 $3.69 Million - $6.36 Million	57,900 New	57,900 $5.56 Million
Q3 2018 Nov 14, 2018	SELL	$75.5 - $96.63 $5.36 Million - $6.86 Million	-70,978 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$74.84 - $100.16 $821,593 - $1.1 Million	10,978 Added 18.3%	70,978 $5.88 Million
Q1 2018 May 15, 2018	BUY	$56.95 - $85.19 $3.42 Million - $5.11 Million	60,000 New	60,000 $4.83 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

Price T Rowe Associates Inc Baltimore, MD

5.82M
Shares

$3.66 Billion
0.36% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.51M
Shares

$2.21 Billion
2.99% of portfolio
Janus Henderson Group PLC London, X0

2.48M
Shares

$1.56 Billion
0.72% of portfolio
Capital World Investors Los Angeles, CA

1.7M
Shares

$1.07 Billion
0.15% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$778 Million
10.11% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account